ImmuPharma PLC | Mutual Funds
Mutual Funds that own ImmuPharma PLC
PFS Chelverton UK Equity Growth Fund
850,000
0.61%
850,000
0.2%
06/30/2017
Aviva Investors Investment Funds ICVC - European Equity Fund
436,614
0.31%
0
0.04%
10/15/2017
0
0%
-1,250,000
0%
05/31/2018
Aviva Investors - European Equity Fund
0
0%
-409,378
0%
06/30/2018
0
0%
-300,000
0%
05/31/2018
| Address |
50 Broadway
London Greater London SW1 H0RG
United Kingdom
|
|
Employees
|
- |
| Website |
http://www.immupharma.com |
| Updated |
07/08/2019 |
| ImmuPharma Plc engages in the research, development, and commercialisation of pharmaceutical products. Its drug candidate, Lupuzor, is a potential treatment for the autoimmune chronic inflammatory disease lupus. The company was founded by Richard Warr and Dimitri F. |
